Kamal Menghrajani: The Limits of AI Healthcare
Doctors might be using AI to cut down on paperwork, but can these tools really be employed in clinical settings? On this week’s podcast, Paul and Rich sit down in the studio with Dr. Kamal Menghrajani, a practicing oncologist and lecturer at Harvard Medical School who was previously a member of the Biden White House’s “Cancer Moonshot” team. After she explains how AI is helping in her work, she lays out its real limitations—and discusses how these technologies can distract from more systemic approaches like better patient prevention and screening. Plus: Are her medical students allowed to use LLMs?
Doctors might be using AI to cut down on paperwork, but can these tools really be employed in clinical settings? On this week’s podcast, Paul and Rich sit down in the studio with Dr. Kamal Menghrajani, a practicing oncologist and lecturer at Harvard Medical School who was previously a member of the Biden White House’s “Cancer Moonshot” team. After she explains how AI is helping in her work, she lays out its real limitations—and discusses how these technologies can distract from more systemic approaches like better patient prevention and screening. Plus: Are her medical students allowed to use LLMs?